iShares Russell Mid-Cap Growth

Most Recent

  • uploads///ecommerce _
    Company & Industry Overviews

    Why Square Jumped ~14% Today

    In the fourth quarter last year, American financial technology firm Square’s (SQ) stock disappointed investors with a massive loss of 43.3%.

    By Jitendra Parashar
  • uploads///ABMD PE MC
    Healthcare

    Analyzing ABMD, BR, and TFX Stocks

    Abiomed’s (ABMD) net income has grown at a three-year and five-year average of 95.1% and 120.4%, respectively.

    By Amanda Lawrence
  • uploads///Graph
    Company & Industry Overviews

    Inside Exelixis’s Label Expansion Collaborations for Cabozantinib

    As a part of the broader lifecycle management for Cabometyx, Exelixis is exploring the drug in combination with other immune checkpoint inhibitors.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Edwards Lifesciences: Expected to Report Robust Revenues in 2017

    Edwards Lifesciences (EW) is confident that it will report total revenue growth in excess of its previous expectations of 10%–14% for 2017.

    By Margaret Patrick
  • uploads///Part
    Company & Industry Overviews

    North America: The Critical Market For Under Armour

    In 2013, the company had 117 factory-house stores and 6 brand stores in North America. Store rollout is up and is expected to be stronger going forward.

    By Phalguni Soni
  • uploads///HALCYON
    Company & Industry Overviews

    Varian’s Halcyon Reaches Milestone Achievements

    Halcyon is the company’s new treatment platform for cancer patients that visually enhances and simplifies image-guided radiotherapy treatments (or IMRT).

    By Sarah Collins
  • uploads///BioMarins Developmental
    Company & Industry Overviews

    BioMarin’s Strong Pipeline Could Be a Long-Term Growth Driver

    After success in the company’s phase 1/2 trial with BMN 270, an investigational gene therapy for hemophilia A, BioMarin Pharmaceuticals (BMRN) is expected to start phase 3 trials.

    By Daniel Collins
  • uploads///Graph
    Company & Industry Overviews

    Can Edwards Intuity Elite Boost Edwards Lifesciences’ Revenues?

    With the Edwards Intuity Elite valve system, Edwards Lifesciences aims to offer a minimally invasive therapy to complex aortic stenosis patients.

    By Margaret Patrick
  • uploads///ANR
    Earnings Report

    What Analysts Are Recommending for Southwest Airlines

    Of the 18 analysts tracking Southwest Airlines (LUV), six (33.3%) have rated the stock a “strong buy,” and another six (33.3%) have recommended a “buy.”

    By Ally Schmidt
  • uploads///Graph
    Company & Industry Overviews

    Abiomed Is Focused on Expanding Impella’s International Presence

    In the last quarter of fiscal 2017, Abiomed (ABMD) reported international market revenue of nearly $10.7 million, a year-over-year (or YoY) rise of ~58%.

    By Margaret Patrick
  • uploads///Analysts Recommendations
    Company & Industry Overviews

    What Analysts Recommend for BioMarin Pharmaceuticals

    A total of 20 analysts were analyzing BioMarin Pharmaceuticals in July 2017. Six analysts recommended a “strong buy,” while nine analysts suggested a “buy.”

    By Daniel Collins
  • uploads///
    Miscellaneous

    Shake Shack’s Valuation Multiple Compared to Its Peers

    Goldman Sachs downgraded Shake Shack from “neutral” to “sell” and gave a negative same-store sales growth forecast of 2.5% for 2Q17.

    By Rajiv Nanjapla
  • uploads///
    Miscellaneous

    Susquehanna: Under Armour Changes Are ‘Temporary Pause’ to Growth

    UAA is covered by 34 Wall Street analysts who together rate the company a 2.9 on a scale of 1.0 for “strong buy” to 5.0 for “sell.”

    By Sonya Bells
  • uploads///
    Miscellaneous

    Has Chipotle’s Stock Price Bottomed Out?

    After posting better 1Q17 earnings on April 25, Chipotle’s stock price rose to $496.14 by May 16, 2017. Since then, it has experienced downward momentum.

    By Rajiv Nanjapla
  • uploads///Graph
    Company & Industry Overviews

    Medicaid Business—A Key Revenue Driver for WellCare Health Plans in 2017

    In 1Q17, WellCare Health Plans’ (WCG) Medicaid business reported revenues close to $2.6 billion, which equals year-over-year growth of ~11.8%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    What’s Really Driving Zoetis’s Margins in 2017?

    Zoetis (ZTS) expects to generate savings of over $300 million in 2017 through its operational efficiency program.

    By Margaret Patrick
  • uploads///_
    Earnings Report

    Why Baskin-Robbins Had Negative Same-Store Sales Growth in 1Q17

    In 1Q17, Baskin-Robbins, which operates under the umbrella of Dunkin’ Brands (DNKN), had SSSG of -2.4% in the United States and -2.0% in international markets.

    By Rajiv Nanjapla
  • uploads///
    Earnings Report

    Under Armour up Top: Underneath the Slowing Revenues in 1Q17

    UAA’s top line expanded 22% YoY (year-over-year) in fiscal 2016 to $4.8 billion, as compared to its 30% average top-line growth between fiscal 2011 to fiscal 2015.

    By Sonya Bells
  • uploads///Marriott analyst ratings
    Earnings Report

    What Do Analysts Recommend for Marriott ahead of 4Q16 Results?

    According to a Reuters consensus, of the 28 analysts tracking Marriott (MAR), five of them (18.0%) have a “strong buy” for the stock.

    By Ally Schmidt
  • uploads///Marriott dividend yield
    Earnings Report

    Could Marriott’s Dividends Rise in the Second Half of 2016?

    Marriott’s cash dividend ratio was 3.0x at the end of 3Q16, which indicates its ability to sustain dividend payouts.

    By Ally Schmidt
  • uploads///
    Earnings Report

    Panera 2.0 Continues to Boost Same-Store Sales Growth in 4Q16

    Same-store sales growth Same-store sales growth (or SSSG), expressed as a percentage, is a measure of the rise in revenue from a company’s existing restaurants over a certain period of time. SSSG is driven by ticket size and traffic. 4Q16 performance Panera Bread (PNRA) posted systemwide SSSG of 0.7%, with company-operated restaurants posting SSSG of […]

    By Rajiv Nanjapla
  • uploads///
    Earnings Report

    What Hampered Under Armour’s 4Q16 Profitability?

    In 4Q16, Under Armour’s adjusted earnings per diluted share stood at $0.23, which was $0.02 lower than what analysts were expecting.

    By Sonya Bells
  • uploads///
    Miscellaneous

    What Does Wall Street Think about Under Armour?

    Under Armour’s (UAA) Class A shares are rated 2.3 on a scale of 1.0 for “strong buy” to 5.0 for “sell.” Class C shares have a higher rating of 1.0.

    By Sonya Bells
  • uploads///
    Earnings Report

    Under Armour Plans to Expand Its International Presence

    International sales account for about 15.0% of UAA’s total sales compared to less than 6.0% in fiscal 2013. It has plans to further expand that business.

    By Sonya Bells
  • uploads///
    Earnings Report

    How Does Wendy’s Valuation Multiple Compare to Its Peers?

    For the next four quarters, analysts are expecting Wendy’s to post EPS growth of $0.40, which represents a decline of 4.2% from the corresponding quarters of the previous year.

    By Rajiv Nanjapla
  • uploads///
    Earnings Report

    Can 3Q16 Results Boost SHAK’s Valuation Multiple?

    Since the announcement of its 2Q16 results on August 10, 2016, Shake Shack (SHAK) EV-to-sales multiple has fallen from 5.1x to 3.7x.

    By Rajiv Nanjapla
  • uploads///
    Earnings Report

    Will Starbucks’ 4Q16 Earnings Boosts Its Share Price?

    Starbucks, a company that operates coffeehouse chains across the world, is scheduled to post its fiscal 4Q16 earnings results after the market closes on November 3, 2016.

    By Rajiv Nanjapla
  • uploads///projections
    Earnings Report

    Edwards Lifesciences Updates 2016 Guidance after 3Q16 Earnings

    Edwards Lifesciences revised its 2016 guidance after reporting a strong 3Q16. The company maintained its sales guidance for the year at the high end of the $2.7 billion–$3 billion range.

    By Sarah Collins
  • uploads///
    Earnings Report

    Weak 3Q16 Earnings Lowered Chipotle’s Valuation Multiples

    Analysts expect Chipotle to post EPS growth of 146% in the next four quarters. Its current share price might have factored in the growth rate.

    By Rajiv Nanjapla
  • uploads///
    Earnings Report

    Here’s Why Under Armour Stock Fell on October 25

    Under Armour’s massive fall was a result of a warning that came from the company’s management regarding a slowdown in sales growth over the next two years.

    By Sonya Bells
  • uploads///
    Earnings Report

    Panera Needs Its 3Q Earnings to Be in Line with Higher Guidance

    Panera Bread (PNRA), a fast-casual restaurant chain, is set to announce its 3Q16 earnings after the market closes on October 25, 2016.

    By Rajiv Nanjapla
  • uploads///
    Earnings Report

    Are Analysts as Excited about Under Armour as Its Customers?

    Under Armour (UA) has witnessed a rise in its debt over the last few years. The company was recently penalized for its rising debt levels and high valuations.

    By Sonya Bells
  • uploads///
    Earnings Report

    UA Investors Enjoy These Pros, Frown upon These Cons

    Among Under Armour’s primary strengths is its strong business model, which shows substantial potential for further growth.

    By Sonya Bells
  • uploads///
    Earnings Report

    How International Sales Are Driving Under Armour’s Top Line

    Under Armour’s products are sold in North America, Europe, the Middle East, Africa, the Asia-Pacific region, and Latin America. Its revenue came in at $1 billion in 2Q16.

    By Sonya Bells
  • uploads///
    Earnings Report

    How Chipotle’s Valuation Multiple Compares with Peers’

    Valuation multiple Investors should look at valuation multiples when deciding whether to buy or sell a stock. Valuation multiples are driven by perceived growth, risk and uncertainties, and investors’ willingness to pay for a stock. Analysts use various multiples to evaluate a stock. In this article, we’ll use the PE (price-to-earnings) ratio due to its […]

    By Rajiv Nanjapla
  • uploads///
    Miscellaneous

    Chorizo Is Now Available at All Chipotle Restaurants

    On October 3, 2016, Chipotle Mexican Grill (CMG) announced that chorizo would be available in all its US restaurants as of October 4, 2016.

    By Rajiv Nanjapla
  • uploads///
    Earnings Report

    What Analysts Recommend for DRI ahead of Its Fiscal 1Q17 Earnings

    As of September 27, 2016, Darden Restaurants was trading at $61.5. This price may already have priced in the estimates we’ve discussed in this series.

    By Rajiv Nanjapla
  • uploads///
    Earnings Report

    Why Analysts Expect DRI to Post Positive Same-Store Sales Growth

    Analysts are expecting Darden Restaurants (DRI) to post systemwide same-store sales growth of 1.6% in fiscal 1Q17 compared to 3.4% in fiscal 1Q16.

    By Rajiv Nanjapla
  • uploads///IFF
    Basic Materials

    International Flavors and Fragrances to Acquire David Michael

    On September 13, International Flavors and Fragrances (IFF) announced that it entered into an agreement to acquire food flavor company David Michael.

    By Peter Neil
  • uploads///revenues by segment
    Company & Industry Overviews

    EW Poised to Carve Out More Prosthetic Heart Valve Market Share

    Edwards Lifesciences’ SHV Therapy segment contributed approximately 26% to the company’s total sales in 2Q16.

    By Sarah Collins
  • uploads///BURL Margins
    Earnings Report

    Key Drivers Behind Burlington Stores’ 2Q16 Margin Expansion

    Burlington Stores’ gross margin, based on total revenue, improved by about 40 basis points to 39.9% in 2Q16 due to higher initial markup.

    By Sirisha Bhogaraju
  • uploads///Part  Graph
    Basic Materials

    Why FMC’s Health and Nutrition Segment’s Revenue Fell in 2Q16

    In 2Q16, FMC Corporation’s (FMC) Health and Nutrition segment reported revenue of $195 million, representing 24.1% of FMC’s total revenue.

    By Peter Neil
  • uploads///Graph
    Company & Industry Overviews

    ALNY Completes Enrollment for Patisiran’s Phase 3 Trial in 2016

    In 1Q16, Alnylam Pharmaceuticals (ALNY) completed enrollment of clinical subjects for its Phase 3 trial, Apollo. This trial aims to study the efficacy and safety of Patisiran as a treatment for hereditary ATTR amyloidosis with polyneuropathy

    By Margaret Patrick
  • uploads///stz Margins
    Earnings Report

    Can Constellation Brands Afford Margin Expansion in Fiscal 1Q17?

    In fiscal 4Q16, which ended on February 29, 2016, Constellation Brands’ gross margin expanded by 100 basis points to 45.1%, driven by the company’s premiumization efforts.

    By Sirisha Bhogaraju
  • uploads///Part
    Company & Industry Overviews

    Analyzing Foot Locker’s Historical Capital Returns Performance

    Foot Locker (FL) has earned above-average returns on its capital investments over the past five years.

    By Phalguni Soni
  • uploads///Part
    Company & Industry Overviews

    Foot Locker’s e-Commerce Sales Growth: Potential and Prospects

    Foot Locker (FL) operates several e-commerce websites under the Foot Locker and other store banners. It reports e-commerce sales under the direct-to-customer segment.

    By Phalguni Soni
  • uploads///
    Company & Industry Overviews

    What is Chipotle Doing to Win Back Its Customers’ Loyalty?

    The E. coli outbreak seriously dented Chipotle Mexican Grill’s (CMG) image.

    By Rajiv Nanjapla
  • uploads///Part
    Company & Industry Overviews

    Returns Performance: The Rise of Skechers’ Stock

    After being a loss-making company in 2011, Skechers (SKX) has engineered a resurgence in financial performance from 2012 to the present.

    By Phalguni Soni
  • uploads///Part
    Company & Industry Overviews

    How Does Skechers Manage Its Inventory and Distribution?

    In recent years, Skechers has reported improved working capital metrics. The company’s inventory turnover (or ITR) rose from 2.9x in 2013 to 3.2x in 2015.

    By Phalguni Soni
  • uploads///Q Stock overview
    Company & Industry Overviews

    Why Coty’s Stock Price Isn’t Showing Much Momentum

    On June 13, 2016, Coty’s (COTY) stock price was trading at $26.36. The stock price has risen 5.7% year-to-date (or YTD) and 29.0% since January 2015.

    By Penny Morgan
  • uploads///product portfolio
    Company & Industry Overviews

    A Brief Look at Dentsply Sirona’s Business Model

    Dentsply Sirona (XRAY) offers a broad portfolio of dental equipment and consumables that have urological and surgical applications.

    By Sarah Collins
  • uploads///Part
    Consumer

    Will Strong Sales Growth Propel LULU’s Future Earnings?

    Lululemon Athletica’s guidance assumes a slightly higher tax rate compared to the prior year and no share repurchases in fiscal 2017.

    By Phalguni Soni
  • uploads///
    Company & Industry Overviews

    Which Fast-Food and Pizza Company Leads the Pack in Retail Space Utilization?

    In 1Q16, seven of our eight fast-food restaurant companies under review generated a median revenue of $167 per square foot.

    By Rajiv Nanjapla
  • uploads///Part
    Consumer

    Sales Expectations: Why e-Commerce Upside Is Important for LULU

    In fiscal 1Q17, LULU expects revenue ranging from $483 million–$488 million, an implied growth rate of 14%–15.2% over fiscal 1Q16.

    By Phalguni Soni
  • uploads///recurring revenue model
    Company & Industry Overviews

    What Does Intuitive Surgical’s Business Model Look Like?

    Intuitive Surgical (ISRG) defines its business model as a “razor/razor blade” model. What does this mean?

    By Sarah Collins
  • uploads///ROST Q EPS
    Earnings Report

    What Do Analysts Expect from Ross Stores’ Fiscal 1Q16 Earnings?

    Off-price retailer Ross Stores (ROST) is scheduled to announce its results for fiscal 1Q16 on May 19. In fiscal 4Q15, Ross Stores’ adjusted EPS increased by 10% to $0.66.

    By Sirisha Bhogaraju
  • uploads///top  oncology drugs
    Earnings Report

    Medivation Sees Growth in Xtandi: A Major Oncology Drug

    Medivation (MDVN) is an oncology-focused biopharmaceutical company, and Xtandi as its only approved drug.

    By Jillian Dabney
  • uploads///JWN Margins
    Earnings Report

    Can Nordstrom’s Productivity Efforts Give Higher 1Q16 Margins?

    In April 2016, Nordstrom announced certain operating model improvements to generate savings of about $60 million in fiscal 2016.

    By Sirisha Bhogaraju
  • uploads///
    Earnings Report

    Why Did Papa John’s Revenue Decline in 1Q16?

    With unit growth expected to dominate the second part of 2016, analysts are expecting Papa John’s to register a revenue growth of 3.4% from $1.6 billion in 2015 to $1.7 billion in 2016.

    By Rajiv Nanjapla
  • uploads///xyrem
    Company & Industry Overviews

    Xyrem: Jazz Pharmaceuticals’ Key Product

    Xyrem is the only FDA-approved drug for both cataplexy and EDS (excessive daytime sleepiness) with narcolepsy.

    By Jillian Dabney
  • uploads///
    Company & Industry Overviews

    Behind Buffalo Wild Wings’ Investments in Emerging Brands

    To diversify, Buffalo Wild Wings (BWLD) has invested in PizzaRev, a fast-casual pizza restaurant, and R Taco, a fast-casual taco restaurant.

    By Rajiv Nanjapla
  • uploads///Xtandi
    Company & Industry Overviews

    Xtandi: A Major Prostate Cancer Drug

    Xtandi’s oncology prescriptions grew annually by ~40% in fiscal 2015. Similarly, the drug’s overall treatment duration over past three years has grown significantly.

    By Jillian Dabney
  • uploads///ANR
    Company & Industry Overviews

    What Are Analysts’ Recommendations for Edwards Lifesciences?

    As of April 12, 2016, about 73.1% of analysts surveyed by Bloomberg rated Edwards Lifesciences as a “buy.”

    By Sarah Collins
  • uploads///Part
    Consumer

    What Is Wall Street Projecting for Under Armour’s 1Q16 Revenue?

    According to the Wall Street analyst consensus, Under Armour is expected to post revenues of $1.04 billion in the quarter, an increase of 28.8% over 1Q15.

    By Phalguni Soni
  • uploads///
    Company & Industry Overviews

    What Do Analysts Recommend for Fast Casual Restaurants?

    In this article, we’ll discuss analysts’ revised estimates and recommendations for fast casual companies following the companies’ 4Q15 results.

    By Rajiv Nanjapla
  • uploads///RPM
    Company & Industry Overviews

    Can the Southwest Effect Help Grow Traffic?

    Southwest Airlines (LUV) still has some edge over legacy carriers, such as its recent entry into international markets using the Southwest Effect.

    By Ally Schmidt
  • uploads///
    Company & Industry Overviews

    How is Chipotle Rebuilding Its ‘Food With Integrity’ Image?

    Chipotle declared its intention of regaining its customers’ loyalty and to establish testing and safety protocols that ensure the quality of its products. It conducted a comprehensive reassessment of its supply chain and restaurant practices and implemented a variety of measures.

    By Rajiv Nanjapla
  • uploads///JWN Sales Q
    Earnings Report

    Nordstrom Missed 4Q15 Sales Guidance on Weak Full-Line Store Sales

    The 4Q15 sales of upscale department store Nordstrom (JWN) came in at $4.19 billion, missing the consensus analysts’ estimate of $4.22 billion. In this series, we will discuss the company’s earnings, store growth plans, planned capital spending, and the outlook for fiscal 2016.

    By Sirisha Bhogaraju
  • uploads///
    Earnings Report

    How Is Panera Bread Planning to Expand Its Business?

    In fiscal 2016, Panera Bread (PNRA) is set open 90–100 new restaurants, with the majority of new openings being company-operated restaurants. The company has set to convert 200 of its company-operated restaurants to Panera 2.0.

    By Rajiv Nanjapla
  • uploads///Graph
    Earnings Report

    Will Increasing Scale and Diversification Boost Centene’s Revenues?

    After the closure of Centene-Health Net Deal, Centene expects to benefit from increased scale of operations and diversification of revenue base.

    By Margaret Patrick
  • uploads///FQ Geographical
    Earnings Report

    Why Does Coty Use Acquisitions to Expand Geographically?

    Coty (COTY) markets its beauty and cosmetic products in more than 130 countries and territories. Coty derives its revenue from three geographical regions.

    By Penny Morgan
  • uploads///Macys price movement
    Company & Industry Overviews

    Macy’s Stock Rises on News of Productivity Initiatives

    The stock market reacted positively to news of Macy’s (M) productivity initiatives. Macy’s stock rose 2% on January 7, a day after the announcement.

    By Sirisha Bhogaraju
  • uploads///
    Miscellaneous

    Newell Rubbermaid–Jarden Deal: Strategic Rationale

    Strategic rationale of the deal Both Newell Rubbermaid (NWL) and Jarden (JAH) are US-based consumer products conglomerates operating in diverse industries, with presences in several global markets. Both companies have strong portfolios of leading brands that are number one or number two in their categories. The combined company will have a concentrated portfolio of brands, […]

    By Sonya Bells
  • uploads///
    Miscellaneous

    Newell Rubbermaid–Jarden Deal: Acquirer versus Target

    Newell Rubbermaid’s sales for the year ending December 2014 stood at $5.7 billion. Jarden’s sales for the same period stood at $8.3 billion.

    By Sonya Bells
  • uploads///JWN stock price
    Earnings Report

    Nordstrom’s Stock Underperformed Other Off-Price Retailers

    As of November 4, Nordstrom’s stock price has fallen by 11.3% to $66.42 since the announcement of the company’s 2Q15 results on August 13.

    By Sirisha Bhogaraju
  • uploads///part
    Earnings Report

    Why Motorola Solutions Expects a YoY Revenue Decline in 4Q15

    In 4Q15, Motorola expects its revenues to decline by 6–8% YoY compared to 4Q14, assuming an unfavorable foreign currency impact of $65 million.

    By Adam Rogers
  • uploads///part
    Earnings Report

    Gauging the Foreign Currency Exchange Impact on Motorola’s 3Q15

    Motorola’s revenues declined by 1% YoY primarily due to unfavorable currency exchanges. Its sales, however, increased by 3% on a constant currency basis.

    By Adam Rogers
  • uploads///Screen Shot    at
    Earnings Report

    Motorola Solutions’ 3Q15 Results: Stock Reaction to Low Guidance

    On November 4, Motorola reported its 3Q15 revenues at $1.4 billion, a 1% YoY decrease including $54 million from unfavorable foreign currency exchange.

    By Adam Rogers
  • uploads///Kellogg Companys Dividend
    Earnings Report

    Kellogg Company’s Outlook for Fiscal 2016

    On October 23, the Kellogg Company announced that its Board of Directors declared a dividend of $0.50 per share on the company’s common stock.

    By Sushree Mohanty
  • uploads///Geographical presence
    Company & Industry Overviews

    Coty’s Efforts to Grow Its Geographic Footprint

    In fiscal 2015, Coty clocked global sales of $4.4 billion, with the highest geographic exposure coming from the EMEA region.

    By Penny Morgan
  • uploads///Porters
    Company & Industry Overviews

    Analyzing Coty’s Level of Competition

    High-end companies like Coty rely on repeat customers and mainly compete on the basis of product quality and product differentiation.

    By Penny Morgan
  • uploads///Keurigs Sales
    Company & Industry Overviews

    Can Keurig Kold Add Some Fizz to Keurig’s Sales?

    Keurig’s sales in the third quarter of fiscal 2015 ended June 27, 2015, declined by 5.2% to $969.6 million, due to declines in brewer sales and pod sales.

    By Sirisha Bhogaraju
  • uploads///Valuation
    Earnings Report

    Key Department Store Stocks Underperform in the Market

    As of September 4, department store stocks for Macy’s fell by 11.1% since the start of 2015. Despite 1H15 sales growth, Nordstrom’s stock also fell by 7%.

    By Sirisha Bhogaraju
  • uploads///Department store sales H
    Earnings Report

    Nordstrom Steals Thunder from Department Store Peers in 1H15

    Nordstrom reported a 9.4% rise in total revenue for 1H15. The sales growth was due to growth from full-line stores, online businesses, and off-price stores.

    By Sirisha Bhogaraju
  • uploads///Other beverage categories
    Company & Industry Overviews

    Dr Pepper’s Prospects in Other Non-Carbonated Beverages

    Dr Pepper Snapple adopted a strong strategy by acquiring an 11.7% stake in BodyArmor. But it could grow more in other non-carbonated beverage categories.

    By Sirisha Bhogaraju
  • uploads///allscripts
    Fund Managers

    Blue Harbour Ups its Stakes in Allscripts Healthcare Solutions

    Blue Harbour raised its stakes in Allscripts Healthcare Solutions (MDRX) in 4Q14. The company accounts for 5.91% of the fund’s portfolio in 4Q14.

    By Patricia Garner
  • uploads///topholding
    Fund Managers

    Blue Harbour Sells Key Positions in 4Q14

    Blue Harbour Group manages capital on behalf of pension funds, endowments, and other institutional investors.

    By Patricia Garner
  • uploads///ALSN_FinStats
    Fund Managers

    Allison Transmission Gets a 79% Boost in TPG-Axon’s 4Q Portfolio

    TPG-Axon boosted its holdings in Allison Transmission Holdings (ALSN) in 4Q14, increasing the number of shares a whopping 79%.

    By Stuart McKenzie
  • uploads///AXTA
    Fund Managers

    TPG-Axon Opens a New Position in Axalta Coating

    TPG-Axon Management initiated a new position in Axalta Coating Systems Ltd (AXTA) by purchasing 2,409,701 shares of the company, representing 4.7% of the fund’s 4Q14 portfolio.

    By Stuart McKenzie
  • uploads///
    Fund Managers

    Magnetar Purchases New Stake in Restaurant Brands International

    Magnetar Capital added new stake in Restaurant Brands International (QSR) in 4Q14. The position represented 0.73% of its holdings at the end of the year.

    By Santiago Solari
  • uploads///ZTS
    Fund Managers

    Highfields Capital Adds Zoetis to Its 4Q14 Portfolio

    Zoetis (ZTS) is the animal health business that Pfizer (PFE) spun off in June 2013.

    By Stuart McKenzie
  • uploads///Part
    Earnings Report

    Why Under Armour Had Back-To-Back Acquisitions

    Under Armour’s (UA) back-to-back acquisitions this year could help it claim the top position from the market leader—NIKE.

    By Phalguni Soni
  • uploads///Part
    Earnings Report

    Expanding Product Platforms Drive Armour’s Revenue Gains

    Under Armour’s footwear revenues grew 41.8% to $0.3 billion in Q1–Q3 2014. Under Armour is a much newer entrant in the NIKE-dominated footwear space.

    By Phalguni Soni
  • uploads///Part
    Company & Industry Overviews

    Coach Acquires Stuart Weitzman In Line With Broader Strategy

    Stuart Weitzman is a vertically integrated high-profile footwear manufacturer. The company sells footwear targeted at the premium women’s market.

    By Phalguni Soni
  • uploads///Part
    Company & Industry Overviews

    Under Armour’s Cost Profile And Outlook

    Under Armour, Inc.’s cost of goods sold margins have been fairly steady over the years. SG&A costs are likely to trend higher in the near to medium term.

    By Phalguni Soni
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.